Allergan plc Securities Litigation (2018)

If you purchased a significant amount of shares of Allergan plc. (NYSE: AGN), you have certain options. Investors should register for updates.

 

Lawsuit Overview

Defendant:Allergan plc.
Date Filed:December 21st, 2018
Sector:Health Care
Industry:Major Pharmaceuticals

Plaintiff's law firm issued a press release on December 21, 2018, announcing the filing of the lawsuit. According to the press release, the Complaint alleges that, during the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts. Specifically, the Complaint alleges that throughout the Class Period Allergan concealed from investors the fact that the Company's CE Mark for its textured breast implants and tissue expanders was expiring in Europe.

Sign up for free to create a personalized portfolio with tracking and e-mail alerts for Allergan plc.

 
First Identified Complaint

Thomas F. Cook, et al. v. Allergan plc, et al.

Date Filed:December 21st, 2018
Class Period Start:February 24th, 2017
Class Period End:December 19th, 2018
First Identified Complaint Filings
#Document TitleFiling Date